The evolving definition of a chondrodysplasia?

Pediatric Pathology and Molecular Medicine

Volumn 22, Issue 1, 2003, Pages 47-52

  Horton, William A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Shriner's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DEVELOPMENT; CHONDRODYSPLASIA; EVOLUTION; GENETIC DISORDER; GROWTH; HUMAN; PRIORITY JOURNAL;

HUMANS; MOLECULAR BIOLOGY; MUTATION; OSTEOCHONDRODYSPLASIAS;

EID: 0037220135     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950307694     Document Type: Article

References (42)

1. Rimoin DL. The chondrodystrophies. Adv. Hum. Genet. 1975;5:1-118.
2. Maroteaux P, Lamy M. Les formes pseudo-achondroplasiques des dysplasies spondylo-epiphysaires. Presse Med. 1959;67:383-386.
3. Hobaek A. Chondrodysplasia hereditaria infantilis. In Problems of Hereditary Chondrodysplasias. Oslo: Oslo University Press, 1961;82-95.
4. Ford N, Silverman FN, Kozlowski K. Spondyloepiphyseal dysplasia (pseudoachondroplastic type). Am J Roentgenol 1961;86:462-472.
5. Maroteaux P, Savart P, Lefebvre J, Royer P. Les formes partielles de la dysostose metaphysaire. Presse Med 1963;71:1523-1526.
6. McKusick VA. Metaphyseal dysostosis and thin hair: A new recessively inherited syndrome? Lancet 1964;1:832-833.
7. Kozlowski K, Maroteaux P, Spranger JW. La dysostose spondylo-metaphysaire. Presse Med 1967;75:2769-2774.
8. Langer LO, Jr., Spranger JW, Greinacher I, Herdman RC. Thanatophoric dwarfism. A condition confused with achondroplasia in the neonate, with brief comments on achondrogenesis and homozygous achondroplasia. Radiology 1969;92(2): 285-294.
9. Rubin P. Dynamic Classification of Bone Dysplasias. Chicago: Year Book Medical Publishers, 1964.
10. Saldino RM. Lethal short-limbed dwarfism: Achondrogenesis and thanatophoric dwarfism. Am J Roentgenol 1971;112(1):185-197.
11. Spranger JW, Langer LO, Wiedemann H-R. Bone Dysplasias, An Atlas of Constitutional Disorders of Skeletal Development. Philadelphia: W.B. Saunders, 1974.
12. Maroteaux P. Bone Diseases of Children. Philadelphia: Lippincott, 1979.
13. Wynne-Davies R, Hall CM, Apley AG. Atlas of Skeletal Dysplasias. Edinburgh: Churchill Livingstone, 1985.
14. Spranger J. Radiologic nosology of bone dysplasias. Am J Med Genet 1989;34(1): 96-104.
15. Spranger J, Maroteaux P. The lethal osteochondrodysplasias. Adv Hum Genet 1995;19:1-103.
16. Taybi H, Lachman RS. Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias, 4th Ed. New York: Mosby, 1996.
17. Rimoin DL, Hughes GN, Kaufman RL, Rosenthal RE, McAlister WH, Silberberg R. Endochondral ossification in achondroplastic dwarfism. N Engl J Med 1970;283(14):728-735.
18. Rimoin DL, Hollister DW, Lachman RS, Kaufman RL, McAlister WH, Rosenthal RE, et al. Histologic studies in the chondrodystrophies. Birth Defects Orig Artic Ser 1974;10(12):274-295.
19. Rimoin DL. Histopathology and ultrastructure of cartilage in the chondrodystrophies. Birth Defects Orig Artic Ser 1974;10(9):1-18.
20. Stanescu V, Stanescu R, Maroteaux P. Morphological and biochemical study of growth cartilage in osteochondrodysplasias. Arch Fr Pediatr 1977;34 Suppl 1:I-LXXX.
21. Sillence DO, Rimoin DL, Lachman R. Neonatal dwarfism. Pediatr Clin North Am 1978;25(3):453-483.
22. Sillence DO, Horton WA, Rimoin DL. Morphologic studies in the skeletal dysplasias. Am J Pathol 1979;96(3):813-870.
23. Spranger J. Bone dysplasia "families." Pathol Immunopathol Res 1988;7(1-2):76-80.
24. Spranger J. International classification of osteochondrodysplasias. International Working Group on Constitutional Diseases of Bone. Eur. J. Pediatr. 1992;151: 407-415.
25. Murray LW, Rimoin DL. Abnormal type II collagen in the spondyloepiphyseal dysplasias. Pathol Immunopathol Res 1988;7(1-2):99-103.
26. Murray LW, Bautista J, James PL, Rimoin DL. Type II collagen defects in the chondrodysplasias. I. Spondyloepiphyseal dysplasias. Am J Hum Genet 1989;45(1):5-15.
27. Lee B, Vissing H, Ramirez F, Rogers D, Rimoin D. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science 1989;244:978-980.
28. Bogaert R, Tiller GE, Weís MA, Gruber HE, Rimoin DL, Cohn DH, et al. An amino acid substituion (Gly853Glu) in the collagen alpha1 (II) chain produces hypochondrogenesis. J Biol Chem 1992;267:22522-22536.
29. Tavormina P, Shiang R, Thompson L, Zhu Y, Wilkin D, Lachman R, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995;9:321-328.
30. Tavormina PL, Rimoin DL, Cohn DH, Zhu YZ, Shiang R, Wasmuth JJ. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet 1995;4(11):2175-2177.
31. Tiller GE, Polumbo PA, Weis MA, Bogaert R, Lachman RS, Cohn DH, et al. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type. Nat Genet 1995;11(1):87-89.
32. Wilkin DJ, Bogaert R, Lachman RS, Rimoin DL, Eyre DR, Cohn DH. A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. Hum Mol Genet 1994;3(11):1999-2003.
33. Mortier GR, Wilkin DJ, Fernandes R, Eyre DR, Rimoin DL. Five new COL2A1 mutations in the type II collagen disorders. Am J Hum Genet 1995;57:A221.
34. Hastbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): Evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 1996;58(2):255-262.
35. Superti-Furga A, Hastbacka J, Wilcox WR, Cohn DH, van der Harten HJ, Rossi A, et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet 1996;12(1):100-102.
36. Briggs MD, Mortier GR, Cole WG, King LM, Golik SS, Bonaventure J et al. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 1998;62(2):311-319.
37. Bellus GA, Bamshad MJ, Przylepa KA, Dorst J, Lee RR, Hurko O, et al. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): Phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. Am J Med Genet 1999;85(1):53-65.
38. Braverman N, Lin P, Moebius FF, Obie C, Moser A, Glossmann H, et al. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome. Nat Genet 1999;22(3):291-294.
39. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 1999;21(3):302-304.
40. Hou WS, Bromme D, Zhao Y, Mehler E, Dushey C, Weinstein H, et al. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 1999;103(5):731-738.
41. Mortier GR, Weis M, Nuytinck L, King LM, Wilkin DJ, De Paepe A, et al. Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet 2000;37(4):263-271.
42. Rimoin DL. International nomenclature and classification of the osteochondrodysplasias. Am J Med Genet 1997;79:376-382.